Glooko offers a Software-as-a-Service (SaaS) application for Diabetes Management.
Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 16, 2021 | Series D | $30M | 1 | — | — | Detail |
Jun 27, 2017 | Series C | $35M | 1 | — | — | Detail |
Mar 17, 2015 | Series B | $16.50M | 1 | Medtronic | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Novo Nordisk | — | Series D |
Medtronic | — | Series C |